IFN-γ |
Activates MΦs and monocytes to release oxygen radicals and TNF-α, IL-l, and IL-6 secretion Blocks the production of IL-10 |
(63–67) |
|
Absence leads to Th2 skewing |
(48) |
IL-12 |
Drives Th1 response and IFN-γ production |
(68) |
|
Controls Th2 expansion and IL-4 production |
(69, 70) |
|
Induces NOS2 expression and NO production |
(71) |
|
Induces cell proliferation and lymphokines production |
(71, 72) |
TNF-α |
Activates the MΦs to kill amastigotes |
(73) |
|
Induces NO production to kill the parasite or inhibit visceralization |
(74) |
|
Induces granuloma response and wound healing process |
(75, 76) |
|
Shows IFN-γ-independent leishmanicidal activity |
(77, 199) |
|
Promotes IL-10 producing T-cells for immune homeostasis |
(78) |
IL-2 |
Activates T-cells and NK cells and induces IFN-γ production |
(79, 80) |
|
Induces the production of IL-4 |
(81) |
|
Endogenous IL-2 shows host protection |
(82) |
|
Exogenous IL-2 exerts anti-leishmanial action even in the absence of IFN-γ |
(83) |
IL-15 |
Synergizes with IL-2 and IL-12 functions |
(84, 85) |
|
Induces T-cell proliferation and inhibits apoptosis, preserves memory T-cells, and induces B-cell maturation and isotype switching |
(86–88) |
|
Activates both Th1 and Th2 subtypes and shows pleiotropic role |
(89, 90) |
|
Stimulates Th1 response, IL-12 production and downregulates IL-4+ Th2 cells |
(86, 91) |
IL-22 |
Promotes inflammatory response and is crucial in tissue repair |
(92, 93) |
|
Protects the liver from chronic infections |
(94) |
|
Induces the production of antimicrobial peptide-β-defensin |
(95) |
|
Complementary to Th1 cytokines and requires IL-6 for production |
(96–98) |
IL-7 |
Induces proliferation of thymocytes, NK and mature T-cells, and production of cytotoxic T-cells |
(99–104) |
|
Promotes the synthesis and secretion of IL-6, TNF-α, IL-1α, IL-1β, and MIP-113 by monocytes |
|
|
With the combination of IFN-γ, it induces TNF-α and NO production to kill the amastigotes |
(105) |
IL-8 |
Promotes the recruitment of neutrophils and granulocytes at lesion site |
(106, 107) |
|
Declines in the serum of active VL and polymorphism at −251 position associates with active VL |
(32, 108) |
IL-23 |
Shows IL-12 independent protection against visceral infection |
(76, 109, 110) |
|
P19 pairs with IL-12p40 to become active and protects the host |
(111) |